3rd Quarter 2021 Inpatient Treatment Outcome Data Available

Paul Marron
Paul Marron
October 1, 2021

3rd Quarter 2021 Inpatient Treatment Outcome Data Now available

Fulfilling its commitment to monitor and measure the effectiveness of its services and programs, and in keeping its pledge to make that effectiveness transparent, Tully Hill’s patient treatment outcomes for the third quarter (7/1/21 through 9/30/21) are now available.

Our outcomes data are specific to patients achieving their treatment goals while being treated in both levels of Inpatient care (medically supervised detox and Inpatient rehabilitation), in this time period. We’ll continue to make this important data available on a quarterly basis throughout 2021 and thereafter.

Our treatment outcomes data are derived from information we submit to our licensing authority, the NY State Office of Addiction Services and Support (OASAS), which it uses to generate and return our treatment outcome results. Treatment plan components that are measured include achievement of alcohol, drug, emotional functioning, family situation, legal, medical, social functioning, and tobacco use goals. It’s important to note that treatment plan goals are individualized and dependent upon diagnosis at evaluation, the individual being treated, and his / her treatment plan.

Besides making available to our universe of stakeholders outcomes with Inpatient treatment goals, we also publicize on our website outcome page equally important data related to patients’ educational and employment statuses; their satisfaction with numerous categories of patient care and our facility environment; and tracking whether patients attended their first clinical aftercare appointment.

Our second quarter outcomes continue to demonstrate a high percentage of treatment goal achievement, patient satisfaction, and aftercare follow-through with our patients.

Tully Hill strongly believes that there is a significant connection between consistent measurement and quality, which is the basis of our commitment to continue to gather and report patient treatment outcomes. We’re committed to using this data to improve even more our patient treatment and care; to continue to inform our patients and families about how well we are faring with our treatment and care efforts; and to likewise continue to communicate as much to our universe of other stakeholders.

Paul Marron

Director of Business Development

Paul Marron, Director of Business Development, joined Tully Hill Chemical Dependency Treatment Center in July 2012. Mr. Marron graduated Magna Cum Laude from both Saint Bonaventure University with a BA, History/Pre-Law and Boston University with his MS, Public Relations. He worked most recently at Central New York Eye & Tissue Bank where he served as their Director of Business Development. He has extensive experience in healthcare administration, contracting, marketing and development in Central New York.